Matthew E Korenberg Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew E Korenberg.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew E Korenberg. Matthew E Korenberg is EVP,Finance & Strategy and CFO in LIGAND PHARMACEUTICALS INC ($LGND) and VP, Finance and CFO in LIGAND PHARMACEUTICALS INC ($LGND) and Director in Qualigen Therapeutics, Inc. ($RTTR).

Latest Insider Trading Transactions of Matthew E Korenberg

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000004
Value of Purchases ($)00000021,189
No. of Sales0000002
Value of Sales ($)000000329,337

Sentiment: All, LGND, RTTR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Option ExerciseA177.5011,5912,057,40311,591
Feb 05 2021LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.0010,819041,75230.9 K to 41.8 K (+34.98 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF156.011,440224,65430,93332.4 K to 30.9 K (-4.45 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.004,803032,37327.6 K to 32.4 K (+17.42 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF156.01671104,68327,57028.2 K to 27.6 K (-2.38 %)
Jan 27 2021LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.002,305028,24125.9 K to 28.2 K (+8.89 %)
Jul 01 2020LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...BuyJ89.0323821,18925,93625.7 K to 25.9 K (+0.93 %)
Jun 08 2020RTTRQualigen Therapeut ...Korenberg Matthew EDirectorOption ExerciseA5.1350,000256,50050,000
Apr 24 2020LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF120.8643552,57415,30315.7 K to 15.3 K (-2.76 %)
Apr 24 2020LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF120.8637745,56415,73816.1 K to 15.7 K (-2.34 %)
Apr 24 2020LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF120.8635442,78416,11516.5 K to 16.1 K (-2.15 %)
Feb 18 2020LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Option ExerciseA95.6830,7502,942,16030,750
Feb 18 2020LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.006,848026,86420 K to 26.9 K (+34.21 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF105.87979103,64720,01621 K to 20 K (-4.66 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.002,305020,99518.7 K to 21 K (+12.33 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF105.871,135120,16218,69019.8 K to 18.7 K (-5.73 %)
Dec 26 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.002,674019,82517.2 K to 19.8 K (+15.59 %)
Sep 03 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...BuyP86.1850043,09117,15116.7 K to 17.2 K (+3.00 %)
Jul 02 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...BuyJ97.0318217,65916,65116.5 K to 16.7 K (+1.11 %)
Feb 13 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Option ExerciseA117.9729,2983,456,28529,298
Feb 13 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.006,404016,46910.1 K to 16.5 K (+63.63 %)
Jan 25 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF111.7861268,40910,06510.7 K to 10.1 K (-5.73 %)
Jan 25 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.002,230010,6778.4 K to 10.7 K (+26.40 %)
Jan 25 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF111.7871379,6998,4479.2 K to 8.4 K (-7.78 %)
Jan 25 2019LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.002,41809,1606.7 K to 9.2 K (+35.86 %)
Aug 29 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Option ExerciseM85.7911,540990,0176,924
Aug 29 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...SellS256.6918,3574,712,0606,74225.1 K to 6.7 K (-73.14 %)
Aug 29 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...BuyM85.7911,540990,01725,09913.6 K to 25.1 K (+85.11 %)
Aug 29 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Option ExerciseM85.7911,540990,0176,924
Aug 29 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...SellS256.6918,3574,712,0606,74225.1 K to 6.7 K (-73.14 %)
Aug 29 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...BuyM85.7911,540990,01725,09913.6 K to 25.1 K (+85.11 %)
Aug 07 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF226.74836189,55513,55914.4 K to 13.6 K (-5.81 %)
Jul 03 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...BuyJ117.8418021,21014,39514.2 K to 14.4 K (+1.27 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Option ExerciseA159.0116,0502,552,11116,050
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF165.8755091,22914,21514.8 K to 14.2 K (-3.73 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.002,004014,76512.8 K to 14.8 K (+15.70 %)
Mar 06 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...GrantA0.003,074012,7619.7 K to 12.8 K (+31.73 %)
Feb 16 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF157.1832651,2419,68710 K to 9.7 K (-3.26 %)
Feb 16 2018LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EEVP,Finance & Strat ...Payment of ExerciseF157.1835455,64210,01310.4 K to 10 K (-3.41 %)
Dec 29 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOPayment of ExerciseF138.661,530212,15010,36711.9 K to 10.4 K (-12.86 %)
Dec 29 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOGrantA0.003,750011,8978.1 K to 11.9 K (+46.03 %)
Nov 17 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOSellS142.636,559935,5108,14714.7 K to 8.1 K (-44.60 %)
Aug 08 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOPayment of ExerciseF122.0660974,33514,70615.3 K to 14.7 K (-3.98 %)
Jul 05 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOBuyJ87.1324321,17115,31515.1 K to 15.3 K (+1.61 %)
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOOption ExerciseA100.3815,2251,528,28615,225
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOGrantA0.003,567015,07211.5 K to 15.1 K (+31.00 %)
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOPayment of ExerciseF100.381,051105,49911,50512.6 K to 11.5 K (-8.37 %)
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOGrantA0.003,450012,5569.1 K to 12.6 K (+37.89 %)
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOPayment of ExerciseF104.2839140,7739,1069.5 K to 9.1 K (-4.12 %)
Feb 28 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOPayment of ExerciseF123.3060975,0909,45710.1 K to 9.5 K (-6.05 %)
Jan 03 2017LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOBuyJ86.37403,45510,10610.1 K to 10.1 K (+0.40 %)
Jul 05 2016LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOBuyJ87.1019617,07210,0669.9 K to 10.1 K (+1.99 %)
Feb 16 2016LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOOption ExerciseA85.7918,4641,584,02718,464
Feb 16 2016LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOGrantA0.003,87009,8706 K to 9.9 K (+64.50 %)
Aug 07 2015LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOOption ExerciseA104.5925,0002,614,75025,000
Aug 07 2015LGNDLIGAND PHARMACEUTI ...Korenberg Matthew EVP, Finance and CFOGrantA0.006,00006,0000 to 6 K

Page:   1